Investor Type | Firm |
Industries | BioTech • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Oncology |
Evidity Health Capital is a venture capital and growth equity firm with a focus on the healthcare sector. Founded in 2014 and previously known as Canepa Healthcare, the firm operates from its offices in New York and Miami. Evidity Health Capital specializes in late-stage investments, concentrating on medical devices, in vitro diagnostics, and digital health innovations that disrupt traditional healthcare practices. Their primary investment thesis revolves around providing growth capital to private companies that have already commercialized their products and are on the cusp of achieving profitability. By targeting this stage of company development, Evidity offers necessary funding and support to help these businesses scale and reach their financial objectives. The firm values a strong evidence-based approach to its investment decisions and is committed to building successful, transformative healthcare businesses. They are known for managing assets that consist of leading, innovative healthcare companies and emphasize a value-focused investment strategy. The team at Evidity is led by three investment partners who bring diverse and complementary skillsets. They share a common background that emphasizes a cohesive approach to investing and business-building. Their portfolio showcases a track record of involvement with leading, innovative, and transformative healthcare companies that have since exited. Additionally, Evidity Health Capital remains connected to the healthcare industry through updates and news shared on their platform.